drugset

drugset / Trial / NCT07698756

A Clinical Study of HRS-8797 in Healthy Participants

NCT07698756 ↗

Phase 1 Not yet recruiting 74 enrolled Chengdu Suncadia Medicine Co., Ltd.

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this phase I study is to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of HRS-8797 in healthy participants.

Timeline

Start: 2026-07
Primary completion: 2026-12
Completion: 2027-01

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	HRS-8797	Unknown	—	Oral

Indications